Even as the pharmaceutical industry is growing steadily, attracting more foreign players into the market, small enterprises that have been depending on contract manufacture for larger players are......
The country's leading drug makers, including Ranbaxy Laboratories, Cipla, Cadila Pharmaceuticals, Nicholas Piramal and Wockhardt, will soon withdraw about 60 drug combinations from the market. The......
More than half of the small-scale pharmaceutical units operational in India have either closed down or indefinitely suspended business activities in the last two years, having being struck by......
India has emerged as one among the top two sourcing hubs for the global pharmaceutical industry along with China, if the trends at CPhI Worldwide - the largest global pharmaceutical ingredients......
Small scale pharmaceutical units in the country are facing an imminent closure owing to lack of business opportunities and hostile regulatory policies. Small scale units account for 30 per cent of......